Built at the Internet Archive
Sites for this collection are listed below. Narrow your results at left, or enter a search query below to find a site, specific URL or to search the text of archived webpages.
Page 1 of 1 (2 Total Results)
Sort By:
Description: Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older.
Loading Wayback Capture Info...
Loading video data...
Subject: Johnson & Johnson, COVID-19 , Vaccines, Food and Drug Administration
Creator: Johnson & Johnson
Publisher: Johnson & Johnson
Source: www.jnj.com
Language: English
Format: website
Type: article
Date: February 27, 2021
Rights: http://rightsstatements.org/vocab/InC/1.0/
Collector: New Brunswick Free Public Library
Description: Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen Pharmaceutical Companies will supply 200 million doses of its COVID-19 vaccine candidate to EU Member States following approval or authorization from regulators.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19 , Vaccines, Johnson & Johnson
Creator: Johnson & Johnson
Publisher: PRnewswire.com
Source: www.prnewswire.com
Language: English
Coverage: New Brunswick, NJ
Format: online newspaper
Type: article
Date: October 8, 2020
Collector: New Brunswick Free Public Library
Rights: http://rightsstatements.org/vocab/InC/1.0/
Page 1 of 1 (2 Total Results)
